# Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort

> **NCT05957653** · PHASE4 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** lidocaine and sufentanil
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05957653
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-07
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05957653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05957653, "Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05957653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*